Detection of Bronchial Neoplasia in Uranium Miners by Autofluorescence Endoscopy (SAFE-1000) by Horvath, T. et al.
Diagnostic and Therapeutic Endoscopy, Vol. 5, pp. 91-98
Reprints available directly from the publisher
Photocopying permitted by license only
(C) 1999 OPA (Overseas Publishers Association) N.V.
Published by license under
the Harwood Academic Publishers imprint,
part of The Gordon and Breach Publishing Group.
Printed in Singapore.
Detection of Bronchial Neoplasia in Uranium Miners by
Autofluorescence Endoscopy (SAFE-IO00)*
T. HORVATHa’f, M. HORVATHOVAa, F. SALAJKAb, B. HABANECc, L. FORETOVAa, J. KANAd,
H. KOUKALOVAa, P. PAFKOe, F. WURSTr, E. NOVOT,NAa, J. PECINAa, V. VAGUNDAa,
R. VRBACKYa, R. TALACa, H. COUPKOVAa,and Z. PACOVSK
aMasaryk Memorial Cancer Institute, Zluty kopec 7, CZ-65653, Brno, Czech Republic, Europe; bClinic of Respiratory
Medicine, Masaryk University Hospital, Bohunice, Brno; CDepartment of Pathology, Medical College Hospital of
Johann Gregor Mendel, Brno; dDepartment of Pneumology, Uranium Mines Hospital, Pribram; eThird Clinic of Surgery,
Charles University Hospital Motol, Prague; Department of Respiratory Medicine, Hospital Decin
The increase in the detection rate for premalignant changes of bronchial epithelium was
studied in 56 symptom-free volunteers from the risk groupofCzech uraniumminers(mean age
50.69 years, meanWLM 21.06 (1 Working Level Month is equal to the absorption of latent
energy of 2.08 10-sJ/m
3 in one month, i.e. 170 working hours)) by the additional employ-
ment of the System of Autofluorescence Endoscopy (SAFE-1000 Pentax) to conventional
white-light bronchoscopy, comparing results with those of bronchial biopsy histopathology
examination. Histopathology using hematoxylin and eosin staining confirmed intraepithelial
neoplasias in 15 areas in 10 persons. White-light bronchoscopy sensitivity was 21.05%, and
specificity 93.7% which an autofluorescence bronchoscopy sensitivity was 78.95%, and
specificity 81.89%.
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INTRODUCTION
Lung cancer is the final stage of a multistep
carcinogenic process [1]. The intraepithelial stage
of neoplastic development typically lasts for a
number of years before invasion occurs [2,3]. In
uranium miners 68% of lung cancers are located in
the central area of the bronchial tree [4].
Mining uranium ore is a high risk factor for lung
cancer which can act after many years leaving the
job in the mines. When the symptoms occur, the
disease is usually advanced [5].
Lung cancer is recognized as an occupational
disease in about 75 Czech uranium miners annually
[6], but the real incidence ismuch higher and reaches
some hundred cases per year. Epidemiologic studies
PS-AFB98: Pilot study Autofluorescence bronchoscopy 1998, SAFE-1000.
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which transmit only 520-600 nm light to an image
intensifier which amplifies to the light. This core of
the system is attached to the eyepiece of a standard
Pentax bronchoscope (FB 18RX) and to the image
monitor(Sony).
FIGURE Autofluorescence- schema.
show themostendangered individuals are theminers
who began work between 20 and 30 years ago [7,8].
The approach to lung cancer in this high risk
group needs to focus attention on detection of
premalignant and early malignant lesions and to
try to prevent the occurrence of malignancies.
Precancerous lesion and early lung cancers are
difficult to detect with conventional white-light
bronchoscopy (WLB) [9]. Woolner et al. noted that
only 29% of all centrally located squamous cell
carcinoma in situ were visible to an experienced
bronchologist [10].
Kato et al. devised a simple fluorescence broncho-
scope system with a conventional Xenon lamp ex-
citation for detection of autofluorescence (Figure 1)
without employing a laser [11,12].
MATERIALS AND METHODS
In the prototype of the System of Autofluorescence
Endoscopy (SAFE- 1000, PENTAX, Tokyo, Japan)
infrared light from aXenon light source Pentax LX-
750P is eliminated by a special infrared filter, and
only blue light of 420-480nm is delivered through
an excitation filter and transmitted via a light guide.
The emitted autofluorescence is transmitted via an
image guide to a TV camera with a Hamamatsu
ICCD Camera ControllerC 3510, fluorescence filter
Subjects
Seventy five subjects were examined, 56 persons of
whom satisfied the conditions of the study: symp-
tom-free volunteers from risk group of Czech ura-
nium miners employed ten ormore years in uranium
mines with WLM evaluated cummulative radon
exposure. They included smokers, ex-smokers and
non-smokers.
Clinical Protocol
Conventional fiberoptic bronchoscopy was per-
formed under local anesthesia. FirstWLB examina-
tion was done, then autofluorescence bronchoscopy
(AFB) by the SAFE-1000 device. Areas suspected of
premalignant changes were studied with alternating
white and blue light and photographs were taken.
Both investigations were recorded on videotape.
Biopsy specimens for histopathology were taken
from all suspected areas on WLB and AFB. Then
random biopsies were carried out in visually normal
areas using both techniques from right carina 2 or
(RC2 and RC1) and left carina or 2 (LC1 and
LC2), and other places as needed. Biopsy specimens
underwent standard staining hematoxylin and
eosin (HE). They were examined by an experienced
pathologist.
All subjects gave informed consent. The approval
for the study was given by the Ministry of Health
Care of the Czech Republic and Czech Medical
Chamber.
RESULTS
Data Analyses
The aim ofthe study was to evaluate the presence of
premalignant changes ofbronchialmucosa in CzechAUTOFLUORESCENCE BRONCHOSCOPY 93
uranium miners and the sensitivity of the SAFE-
1000 in conjunction with conventional WLB using
bronchial biopsy histopathology for objective of
comparison of visual findings of both endoscopy
methods. The 157 biopsies performed in 56 subjects
were divided into the 3 groups:
Group consisted 108 random biopsies from
apparently normal areas on autofluorescence and
WLB, of this 104 specimens showed normal or mild
inflammatory mucosal finding, and 4 specimens
were found to show mild intraepithelial premalig-
nant changes of bronchial mucosa (1 basal cell
hyperplasia, mature squamous metaplasia, 2 mild
dysplasias).
Group 2 included 11 biopsies with alternating
normal respiratory epithelium and squamous meta-
plasia without atypia. They were not included in
AFB sensitivity estimation.
Group 3 consisted 38 specimens from areas with
decreased autofluorescence intensity. Histopathol-
ogy examinations confirmed 15 areas with intra-
epithelial premalignant changes (i.e. true positive
AFB findings), and 23 areas exhibited no pre-
malignancy (i.e. false positive AFB findings). False
positive AFB findings from the histopathologic
point of view consisted 18 specimens which were
found to be normal and 5 biopsies which were found
to show inflammation.
Groups and 3, totally 146 specimens, were
included for estimation of AFB sensitivity in 56
persons aged 39-72 (mean 50.69), mean years
entered to risk 22.48 years, at risk exposure 14.55
years, after exposure 12.20 years, mean WLM
21.06, among them these were 25 smokers (44.64%),
3 ex-smokers (5.36%) and 28 never-smokers (50%).
Significant decrease of autofluorescence intensity
was seen in 38 areas (Table I). Histopathology
TABLE AFB and biopsy results
Histopathology intraepithelial neoplasia
+
AFB
+ 15 23
4 104
19 127
confirmed premalignant changes in 15 areas, 12
were found to be dysplasia, including 5 with
moderate dysplasia (Fig. 2) and 7 with mild
dysplasia (Fig. 3), 2 were found to have metaplasia
and there was basal cell hyperplasia. Another 23
areas had no evidence of premalignancy (Table II).
WLB showed pathological findings in 12 areas in
10 persons (Table III).
The 10 subjects included 6 smokers, ex-smoker
and 3 non-smokers. Histopathology confirmed
intraepithelial neoplasia in 4 areas (3 subjects),
other 8 areas were found premalignancy-free
(Table IV).
The group of 13 persons (19 areas) with evidence
of intraepithelial neoplasia (true positive and false
negative findings) included 3 non-smokers, ex-
smoker and 9 smokers.
FIGURE 2 Moderate dysplasia photo.94 T. HORVATH et al.
The examinations had no complications. The
average time ofthe procedure was 21 minutes (range
7-34min). The sensitivity analysis of (1) WLB
sensitivity 21.05%, specificity 93.7%, false positive
rate 6.3%, false negative rate 78.95%, predictive
value of positive test 33.3%, predictive value of
negative test 88.81%, accuracy 84.25% and (2)AFB
sensitivity 78.95%, specificity 81.89%, false positive
rate 18.11%, false negative rate 21.05%, predictive
value of positive test 39.47%, predictive value of
negative test 96.3%, accuracy 81.51% were
obtained.
FIGURE 3 Mild dysplasia- photo.
DISCUSSION
In order to control and reduce mortality prevention
and early detectionare necessary. Autofluorescence
imaging facilitates the study ofthe natural history of
TABLE III WLB and biopsy results
Histopathology intraepitheilal neoplasia
+
WLB
+ 4 8
15 119
19 127
TABLE II AFB sensitivity
AFB Number of biopsies Histopathology (n 56),
Included
Positive
True
False
Negative
True
False
Non-included
Positive
Negative
Total
15
23
104
4
10
157
5 moderate dysplasias
7 mild dysplasias
2 metaplasias
basal cell hyperplasia
5 inflamed
18 normal
Normal and/or mild inflammation
2 mild dysplasias
metaplasia
basal cell hyperplasia
Normal/metaplasia
Normal/metaplasiaAUTOFLUORESCENCE BRONCHOSCOPY 95
TABLE IV WLB sensitivity
WLB Number of biopsies Histopathology (n- 56)
Included
Positive
True
False
Negative
True
False
Non-included
Negative
Total
119
15
11
157
2 mild dysplasias
metaplasia
basal cell hyperplasia
4 inflammations
cicatricial formation
2 normal
anthracotic pigmentation
Normal, inflammation, other
5 moderate dysplasias
7 mild dysplasias
2 metaplasias
basal cell hyperplasia
Normal/metaplasia
TABLE V Sensitivity and specificity AFB/WLB
White-light Autofluorescence
bronchoscopy (%) bronchoscopy (%)
Sensitivity 21.05 78.95
Specificity 93.70 81.89
lung cancer, provides a means of establishing more
precise intermediate end points in investigations of
efficacy ofchemopreventive drug and has important
implications in the treatment of patients with lung
cancer.
This pilot study proved the sensitivity of the
prototype autofluorescence system for lower grade
atypia of bronchial mucosa. The difficulties at the
beginning of the learning curve have gradually
disappeared. The AFB has 3.75-times higher sensi-
tivity than WLB but about 12% lower specificity
(Table V).
From the analysis of causes of false positivity
(Fig. 4 and Table VI) the groups I, II and IV with
normal histopathology, group III with pathological
findings and group V revealed various causes such
as anatomically related shadows (SAC e.g. Fig. 5),
by motility related abnormality of decreased auto-
fluorescence intensity (MOD), adherent mucus
FIGURE 4 False positivity schema.
(MUC Fig. 6), biopsy accuracy (BAC) technique,
light intensity, effects of distance, etc. (TEC),
anthracotic pigmentation (AP). They emphasize
the necessity for improvement of AFB sensitivity
through training, with regard to inflammatory
changes (INCH) and cicatricial formation (CIC)
from group II seem to be relative common causes of
false positive results of AFB. Unexplained causes
(UNE) remain as a challenge for the future pro-
grams of this technique.96 T. HORVATH et al.
TABLE VI Causes of false positivity of AFB
Number Remark
1. Anatomy andphysiology
SAC Shading due to anatomically configuration
MOD Decreased autofluorescence affected by motility
MUC Mucus
II. Examinator and equipment
BAC Biopsy accuracy
TEC Technique/equipment
III. Pathology
INCH Inflammatory changes
CIC Cicatricial formation
AP Anthracotic pigmentation
IV.
UNE Unexplained
V.
Combinations (I-IV)
> 10 WLB
>4 TEC
>6 WLB
>1
>2 MOD
5 WLB
3 History
>2 WLB
3 WLB
X Frequently
FIGURE 5 False positivity Shading due to anatomically
configuration (SAC). FIGURE 6 False positivity Mucus (MUC).AUTOFLUORESCENCE BRONCHOSCOPY 97
This pilot study raises the question of borderline
autofluorescence diagnosis of emerging atypia.
Accurate evaluation was difficult in 11 specimens.
They were classified as checkered findings according
to histopathology, with alternating normal respira-
tory epithelium and squamous metaplasia without
atypia. Ten specimens were located in areas of
normal autofluorescence intensity i.e. visually nega-
tive AFB findings. The other specimen of this type
came from an area with decreased autofluorescence
intensity i.e. visually positive AFB findings. The 11
specimens were not included in the evaluation of
AFB sensitivity. Further examinations ofspecimens
and follow-up investigation ofthe involved areas are
necessary.
All false negative biopsies (Fig. 7) were found to
be areas oflow grade intraepithelial premalignancy.
Thin epithelial layers could explain the false
negativity of 3 specimens, with basal cell hyper-
plasia, with mature squamous metaplasia, and
with mild dysplasia. False negativity of the second
biopsy with mild dysplasia could have been caused
by low grade atypia, by the biological properties of
the tissue, or by technical reasons.
The detection of basal cell hyperplasia based on
autofluorescence requires consideration of some of
the causes of false positivity and optically non-
significant presence of basal cell hyperplasia in the
FIGURE 7 False negativity schema.
epithelium, the biological properties of the bron-
chial tissue and also the technical characteristics of
the equipment.
The development of methods for detection and
treatment of intraepithelial lesions within the bron-
chial tree is promising both from surgical and
medical points of view [11-16]. Autofluorescence
technology, endobronchial sonography, ultrathin
bronchoscopy, chemoprevention, photodynamic
therapy and electrocautery offer challenges to work
together.
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